Real-World Outcomes of Subcutaneous PHESGO<sup>®</sup> in HER2-Positive Breast Cancer: Pathological Response, Sequencing, and Safety.

Curr Oncol · 2025 · PMC12732124 · PMID 41440186

Europe PMC DOI

hedged sentence

0.0680

closest p · 1.4× alpha

0.0680

boldest claim

The sentences

did not reach statistical significancep = 0.068so close (0.05 < p ≤ 0.1)

17.9%), although this difference did not reach statistical significance ( p = 0.068).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.